[1]屈洪彬,左争辉,李治晓,等.多模态精准手术在老年胶质母细胞瘤治疗中的应用价值[J].临床神经外科杂志,2020,17(04):423-429.[doi:DOI:10.3969/j.issn.1672-7770.2020.04.014]
 QU Hong-bin,ZUO Zheng-hui,LI Zhi-xiao,et al.Applied value of multimodal precision surgery in treatment of glioblastoma in elderly[J].Journal of Clinical Neurosurgery,2020,17(04):423-429.[doi:DOI:10.3969/j.issn.1672-7770.2020.04.014]
点击复制

多模态精准手术在老年胶质母细胞瘤治疗中的应用价值()
分享到:

《临床神经外科杂志》[ISSN:1672-7770/CN:32-1727/R]

卷:
17
期数:
2020年04期
页码:
423-429
栏目:
论著
出版日期:
2020-08-14

文章信息/Info

Title:
Applied value of multimodal precision surgery in treatment of glioblastoma in elderly
文章编号:
202004014
作者:
屈洪彬左争辉李治晓闫兆月赵瑞皎李艳韩倩李冰魏飞彪马春晓
450003 郑州,河南省人民医院,河南大学人民医院,郑州大学人民医院神经外科(屈洪彬,左争辉,李治晓,闫兆月,马春晓),病理科(赵瑞皎),影像科(李艳),放疗科(韩倩),麻醉科(李冰),神经电生理科(魏飞彪)
Author(s):
QU Hong-bin ZUO Zheng-hui LI Zhi-xiao et al.
Department of Neurosurgery, Henan Provincial Peoples Hospital, Zhengzhou 450003, China
关键词:
老年胶质母细胞瘤多模态精准手术预后
Keywords:
elderly glioblastoma glioblastoma multimodal accurate surgery prognosis
分类号:
R739.41
DOI:
DOI:10.3969/j.issn.1672-7770.2020.04.014
文献标志码:
A
摘要:
目的探讨老年胶质母细胞瘤(GBM)患者以手术为主的综合治疗的生存情况和预后相关因素,以及多模态精准手术在老年GBM治疗中的应用价值。方法回顾性分析河南省人民医院神经外科2013年1月—2018年9月手术治疗的102例老年GBM 患者的临床资料。以性别、年龄等17个可能影响因素作为观察指标,通过Kaplan-Meier单因素分析法和Cox回归模型分析筛选出影响老年GBM患者手术治疗预后的因素。根据患者的手术方式分为多模态精准手术组和常规手术组,比较两组患者的手术肿瘤切除程度、术后Karnofsky功能状态(KPS)评分及住院时间。 结果本组患者至术后末次随访的中位总生存时间(overau survival,OS)为11.71个月。单因素分析结果显示:年龄、术前癫痫、KPS评分、肿瘤大小、多模态精准手术、手术切除程度、放化疗及同步放化疗是影响老年GBM患者生存期的因素。多因素Cox回归模型分析显示:患者的年龄(P<0.001)、术前KPS评分(P=0.002)、肿瘤切除程度(P<0.001)、放化疗(P<0.001)、同步放化疗(P=0.046)均为影响预后的独立因素。多模态精准手术组的全切率(73.7%)及术后KSP评分(73.7%)均显著高于常规手术组(37.3%和45.8%);并且比常规手术组明显缩短了住院时间(P<0.05)。MGMT甲基化的患者中,替莫唑胺单药化疗组与同步放化疗组的中位OS比较,差异无统计学意义(P>0.05)。结论术前KPS评分>60分的老年GBM患者接受最大范围的手术切除肿瘤,并术后行短程低频放疗及替莫唑胺化疗等综合治疗,可获得较长的生存期。多模态精准手术可显著提高老年GBM患者的肿瘤切除程度,改善其术后生活质量,缩短住院时间。对于MGMT甲基化的老年GBM患者术后应尽早使用替莫唑胺化疗。
Abstract:
To investigate the postoperative survival and prognostic factors of aged patients with glioblastoma multiform(GBM) treated mainly by surgery and the applied value of multimodal precision surgery in the treatment of glioblastoma in the elderly. Methods The clinical data of elderly glioblastoma patients hospitalized in Department of Neurosurgery, Henan People’s Hospital from January 2013 to September 2018 were analyzed retrospectively. With 17 possible influencing factors such as gender and age as observation indexes, the influencing factors of surgical treatment related prognosis of elderly glioblastoma patients were screened by Kaplan Meier single factor analysis and Cox regression model analysis. According to the application of multimodal precision surgery in operation, the patients were divided into multimodal precision surgery group and conventional surgery group. The extent of resection, postoperative Karnofsky(KPS) and length of stay were compared between the two groups. Results The median overall survival time(OS) was(11.0±0.126) months. Single factor analysis showed that age, preoperative epilepsy, functional status score(KPS), tumor size, multimodal precision surgery, extent of surgical resection, radiotherapy and chemotherapy, and concurrent radiotherapy and chemotherapy were the factors affecting the survival of elderly GBM patients. Multivariate Cox regression model analysis showed that: patients’ age(P<0.001), preoperative KPS(P=0.002), surgical resection extent(P<0.001), radiotherapy and chemotherapy(P<0.001), synchronous radiotherapy and chemotherapy(P=0.046) were independent factors affecting the prognosis of elderly patients with GBM. The total resection rate(73.7%) and the postoperative KSP score(73.7%) of the multimodal precision operation group were significantly higher than those of the conventional operation group(37.3%) and the postoperative KSP score(45.8%), and the hospital stay was shortened, with statistical significance(P<0.05). For MGMT methylated elderly GBM patients, the median OS of temozolomide single drug chemotherapy group was similar to that of concurrent radiotherapy and chemotherapy group, with no statistical significance(P>0.05). Conclusions For the elderly glioblastoma patients whose KPS score is more than 60 before operation, long survival period can still be achieved after the largest range of surgical resection, short-term low-frequency radiotherapy and temozolomide chemotherapy. Multimodal precision surgery can significantly improve the resection extent of glioblastoma in the elderly, improve the quality of life of patients after surgery, and shorten the length of stay. Temozolomide should be used as early as possible in the treatment of GBM patients with MGMT methylation.

相似文献/References:

[1]刘翔宇,孙康健,王汉东,等.荧光实时监测贝伐单抗治疗胶质母细胞移植瘤的实验研究[J].临床神经外科杂志,2016,(02):110.
 LIU Xiang-yu,SUN Kang-jian,WANG Han-dong,et al.Bioluminescent imaging of the impact of bevacizumab on anti-proliferation and angiogenesis in human glioblastomaxenografts in vivo[J].Journal of Clinical Neurosurgery,2016,(04):110.
[2]王天伟,牛小东,毛庆.《艾滋病合并胶质瘤2例报告及文献复习》[J].临床神经外科杂志,2017,14(02):91.
 WANG Tian-wei,NIU Xiao-dong,MAO Qing..Glioblastoma in patient with AIDS:two cases report and review of literatures[J].Journal of Clinical Neurosurgery,2017,14(04):91.
[3]李凌,黄红星,邹叔骋,等.以癫痫为首发症状的胶质母细胞瘤预后影响因素分析[J].临床神经外科杂志,2018,15(03):170.
 LI Ling,HUANG Hong-xing,ZOU Shu-cheng,et al.Prognostic factors of glioblastoma presenting with epilepsy as a primary symptom[J].Journal of Clinical Neurosurgery,2018,15(04):170.
[4]李焦明,甘有均,牛小东,等.不典型胶质母细胞瘤误诊为脑包虫病1例报告及文献复习[J].临床神经外科杂志,2018,15(05):384.[doi:10.3969/j.issn.1672-7770.2018.05.016]
 LI Jiao-ming,GAN You-jun,NIU Xiao-dong,et al.Atypical glioblastoma misdiagnosed as echinococcosis(a report of 1 case and review of literature)[J].Journal of Clinical Neurosurgery,2018,15(04):384.[doi:10.3969/j.issn.1672-7770.2018.05.016]
[5]倪春霞,张玺炜,汪洋,等.顺铂联合替莫唑胺放化疗治疗MGMT启动子未甲基化胶质母细胞瘤的初步研究[J].临床神经外科杂志,2019,16(1):6.[doi:10.3969/j.issn.1672-7770.2019.01.002]
 NI Chun-xia,ZHANG Xi-wei,WANG Yang,et al.Randomized controlled trial design and analysis of preliminary result on cisplatin combined with radiotherapy and concurrent chemotherapy of Temozolomide in MGMT unmethylated glioblastomas[J].Journal of Clinical Neurosurgery,2019,16(04):6.[doi:10.3969/j.issn.1672-7770.2019.01.002]
[6]宋晨,张楠楠,胡喻,等.垂体腺瘤手术治疗中对垂体功能保护的研究[J].临床神经外科杂志,2019,16(2):115.[doi:10.3969/j.issn.1672-7770.2019.02.005]
 SONG Chen,ZHANG Nan-nan,HU Yu,et al.Functional protection during operations of pituitary adenoma[J].Journal of Clinical Neurosurgery,2019,16(04):115.[doi:10.3969/j.issn.1672-7770.2019.02.005]
[7]李顺,邱娜,叶成坤,等.MRI纹理分析在脑脓肿与胶质母细胞瘤鉴别诊断中的应用价值[J].临床神经外科杂志,2019,16(3):245.[doi:10.3969/j.issn.1672-7770.2019.03.013]
 LI Shun,QIU Na,YE Cheng-kun,et al.MRI texture analysis on differential diagnosis of brain abscess and glioblastoma[J].Journal of Clinical Neurosurgery,2019,16(04):245.[doi:10.3969/j.issn.1672-7770.2019.03.013]
[8]高洪元,张玺炜,汪洋,等.TERTp和1p/19q对顺铂联合替莫唑胺同期放化疗治疗MGMT启动子未甲基化GBM的预后影响[J].临床神经外科杂志,2019,16(4):289.[doi:10.3969/j.issn.1672-7770.2019.04.003]
 GAO Hong-yuan,ZHANG Xi-wei,WANG Yang,et al.Prognostic value of TERTp and 1p/19q in cisplatin combined with temozolomide concurrent chemoradiotherapy for newly diagnosed GBM with unmethylated MGMT promoter[J].Journal of Clinical Neurosurgery,2019,16(04):289.[doi:10.3969/j.issn.1672-7770.2019.04.003]
[9]赵亮,章佳跃,刘志远,等.基于多个lncRNA表达量的风险模型预测胶质母细胞瘤患者预后的研究[J].临床神经外科杂志,2020,17(02):164.[doi:DOI:10.3969/j.issn.1672-7770.2020.02.010]
 ZHAO Liang,ZHANG Jia-yue,LIU Zhi-yuan,et al.A lncRNA-expression-based risk model can better improve prognosis prediction in patients with glioblastoma[J].Journal of Clinical Neurosurgery,2020,17(04):164.[doi:DOI:10.3969/j.issn.1672-7770.2020.02.010]

更新日期/Last Update: 2020-08-18